Theobromine

Theobromine

SCHEMBL4465592

Cn1c(=O)[nH]c2nc[nH]c2c1=O.Cn1cnc2c1c(=O)[nH]c(=O)n2C

nearest known ligand 0.68

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2B P29275 8/20 0.68
ADORA2A P29274 6/20 0.68
CYP3A4 P08684 2/20 0.68
PMP22 Q01453 2/20 0.68
MAPK1 P28482 2/20 0.68
LMNA P02545 2/20 0.52
ALDH1A1 P00352 1/20 0.52
MAPT P10636 1/20 0.52
TSHR P16473 1/20 0.52
BLM P54132 1/20 0.52
ADORA3 P0DMS8 7/20 0.47
PDE4A P27815 4/20 0.47
PDE4B Q07343 4/20 0.47
PDE4C Q08493 4/20 0.47
PDE4D Q08499 4/20 0.47
CHIT1 Q13231 1/20 0.46
CHIA Q9BZP6 1/20 0.46
POLB P06746 2/20 0.41
GDA Q9Y2T3 2/20 0.41
PIK3CD O00329 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Theobromine SCHEMBL4018409 0.86 CYP3A4 (0.66) ADORA2BADORA2ACYP3A4PMP22MAPK1
Caffeine SCHEMBL462076 0.86 ADORA2A (0.66) ADORA2BADORA2ACYP3A4PMP22MAPK1
Theobromine SCHEMBL4024314 0.84 MAPK1 (0.75) ADORA2BADORA2ACYP3A4PMP22MAPK1
Theophylline Anhydrous SCHEMBL1655326 0.84 MAPK1 (0.66) ADORA2BADORA2ACYP3A4PMP22MAPK1
Theophylline Anhydrous SCHEMBL2328875 0.83 ADORA2A (0.64) ADORA2BADORA2ACYP3A4PMP22MAPK1
3-Methylxanthine SCHEMBL1892894 0.83 ADORA2B (0.77) ADORA2BADORA2AMAPK1LMNAMAPT
1-Methylxanthine SCHEMBL10996 0.82 ADORA2B (1.00) ADORA2BADORA2ACYP3A4PMP22MAPK1
Theobromine SCHEMBL11599459 0.82 CYP3A4 (1.00) ADORA2BADORA2ACYP3A4PMP22MAPK1
Theobromine SCHEMBL3184 0.82 CYP3A4 (1.00) ADORA2BADORA2ACYP3A4PMP22MAPK1
Theobromine SCHEMBL1690622 0.82 CYP3A4 (1.00) ADORA2BADORA2ACYP3A4PMP22MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1578401-A4 COMPOSITIONS AND METHODS FOR PROMOTING WEIGHT LOSS, THERMOGENESIS, APPETITE SUPPRESSION, LEAN MUSCLE MASS, INCREASING METABOLISM AND BOOSTING ENERGY LEVELS, AND USE AS A DIETARY SUPPLEMENT IN MAMMALS RTC RES & DEV LLC (US) 2009-03-25 EP disclosed
EP-1578401-A2 COMPOSITIONS AND METHODS FOR PROMOTING WEIGHT LOSS, THERMOGENESIS, APPETITE SUPPRESSION, LEAN MUSCLE MASS, INCREASING METABOLISM AND BOOSTING ENERGY LEVELS, AND USE AS A DIETARY SUPPLEMENT IN MAMMALS RTC Research & Development, LLC. (US) 2005-09-28 EP disclosed
US-20040077556-A1 Compositions and methods for promoting weight loss, thermogenesis, appetite suppression, lean muscle mass, increasing metabolism and boosting energy levels, and use as a dietary supplement in mammals RTC RESEARCH AND DEVELOPMENT, LLC 2004-04-22 US disclosed
WO-2003090673-A2 COMPOSITIONS AND METHODS FOR PROMOTING WEIGHT LOSS, THERMOGENESIS, APPETITE SUPPRESSION, LEAN MUSCLE MASS, INCREASING METABOLISM AND BOOSTING ENERGY LEVELS, AND USE AS A DIETARY SUPPLEMENT IN MAMMALS RTC RESEARCH & DEVELOPMENT, LLC. (US) 2003-11-06 WO disclosed
US-20020122800-A1 Treatment of inflammatory oral diseases with a combination of inhibitors of TNF-alpha and immunosuppressive agents SONIS STEPHEN T (US) 2002-09-05 US disclosed